US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ABVC BioPharma, Inc.

1.95

+0.180010.17%

Post-market: 1.950.00000.00%17:45 EDT

Volume:482.09K

Turnover:911.48K

Market Cap:31.69M

PE:-8.70

High:1.98

Open:1.82

Low:1.78

Close:1.77

Loading ...

Overview Company News Filings

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Yukiguni Maitake to Launch 'Mushroom Meat' in Japan

MT Newswires Live

Yukiguni Maitake Launches ‘Mushroom Meat’ to Tackle Protein Crisis

NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression

Neurocrine initiates Phase 3 registrational program for osavampator in MDD

Supernus Pharmaceuticals Says US FDA Approves Label Update for ADHD Treatment Qelbree

MT Newswires Live

Supernus Announces Label Update for Non-Stimulant ADHD Treatment, Qelbree®, Including New Pharmacodynamic Data and Information for Breastfeeding Women

People with ADHD are more likely to die early, according to a new study

businessinsider.com

SPRAVATO® (esketamine) approved in the U.S. as the first and only monotherapy for adults with treatment-resistant depression

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Market Exclusive

ABVC BioPharma and AiBtl BioPharma's Worldwide Business Development Team Participate in the 43rd Annual J.P. Morgan Healthcare Conference

ABVC BioPharma s ADHD and MDD Drug Polygala Tenuifolia a Natural Wonder With Potential of Transforming Mental Health Treatment of More Than 30 Billion Market

Intra-Cellular Therapies Stock Up 34% on J&J's $14.6B Buyout Offer

AiBtl BioPharma Strengthens Partnership With ABVC BioPharma, Paying $150,000 in Licensing Fees

Biogen Offers to Buy Remaining Stake in Sage Therapeutics

ABVC BioPharma, Inc. Granted Additional 180-Day Grace Period to Regain Compliance With Nasdaq Bid Price Requirement

Xenon Outlines Key Corporate Milestone Opportunities for 2025

Press Release: Neuronetics Provides Business Update and Issues 2025 Guidance

Cybin Highlights 2024 Accomplishments and Upcoming Milestones for 2025

ABVC BioPharma and ForSeeCon: An Update on Alliance's Ophthalmology-Related Products

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ABVC/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ABVC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABVC\",,,,,undefined,":{"symbol":"ABVC","market":"US","secType":"STK","nameCN":"ABVC BioPharma, Inc.","latestPrice":1.95,"timestamp":1750104000000,"preClose":1.77,"halted":0,"volume":482093,"hourTrading":{"tag":"盘后","latestPrice":1.95,"preClose":1.95,"latestTime":"17:45 EDT","volume":1122,"amount":2132.8239372000003,"timestamp":1750110339308},"delay":0,"floatShares":14011099,"shares":16250952,"eps":-0.224214,"marketStatus":"Post-Mkt","change":0.18,"latestTime":"06-16 18:21:33 EDT","open":1.82,"high":1.98,"low":1.78,"amount":911479.0133565,"amplitude":0.112994,"askPrice":1.93,"askSize":200,"bidPrice":1.9,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-0.224214,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1750118400000},"marketStatusCode":4,"adr":0,"listingDate":1627963200000,"exchange":"NASDAQ","adjPreClose":1.77,"preHourTrading":{"tag":"盘前","latestPrice":1.81,"preClose":1.77,"latestTime":"09:22 EDT","volume":10110,"amount":18694.800345,"timestamp":1750080164032},"postHourTrading":{"tag":"盘后","latestPrice":1.95,"preClose":1.95,"latestTime":"17:45 EDT","volume":1122,"amount":2132.8239372000003,"timestamp":1750110339308},"volumeRatio":1.914126},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABVC\",,,,,undefined,":{"symbol":"ABVC","floatShares":14011099,"roa":"-10.91%","roe":"-42.42%","lyrEps":-0.419983,"volumeRatio":1.914126,"shares":16250952,"dividePrice":0,"high":1.98,"amplitude":0.112994,"preClose":1.77,"low":1.78,"week52Low":0.4,"pbRate":"5.86","psRate":"62.33","week52High":1.98,"institutionHeld":0,"latestPrice":1.95,"committee":-0.904762,"eps":-0.224214,"divideRate":0,"volume":482093,"delay":0,"ttmEps":-0.224214,"open":1.82,"prevYearClose":0.59,"prevWeekClose":1.77,"prevMonthClose":1.37,"prevQuarterClose":1.06,"fiveDayClose":1.62,"twentyDayClose":1.48,"sixtyDayClose":0.665},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ABVC\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2509717127","title":"Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2509717127","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509717127?lang=en_us&edition=fundamental","pubTime":"2025-02-08 05:30","pubTimestamp":1738963800,"startTime":"0","endTime":"0","summary":"MALVERN, Pa., Feb.  07, 2025  (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/07/3023027/0/en/Neuronetics-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00BGHQF748.EUR","NDAQ","BK4112","LU2210149790.SGD","STIM","BK4588","ABVC","LU2095319765.USD","BK4585","BK4082","IE00B64PRP62.GBP","IE00BKPKM429.USD","BK4139",".IXIC","LU2210150020.SGD"],"gpt_icon":0},{"id":"2509250642","title":"Yukiguni Maitake to Launch 'Mushroom Meat' in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2509250642","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509250642?lang=en_us&edition=fundamental","pubTime":"2025-02-06 06:39","pubTimestamp":1738795178,"startTime":"0","endTime":"0","summary":"Yukiguni Maitake  will launch its plant-based \"Mushroom Meat\" series in Japan on Feb. 18, using its premium maitake mushrooms to mimic a meat-like texture, according to a Wednesday filing on the Tokyo Stock Exchange.The lineup includes ready-to-use mushroom meat, three sauce varieties-tomato, ajillo, and sesame dandan-and a rice mix. The company sees the product as a response to rising demand for meat alternatives amid global food concerns.Price : $1187.00, Change: $+34, Percent Change: +2.95%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ABVC"],"gpt_icon":0},{"id":"2509742768","title":"Yukiguni Maitake Launches ‘Mushroom Meat’ to Tackle Protein Crisis","url":"https://stock-news.laohu8.com/highlight/detail?id=2509742768","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509742768?lang=en_us&edition=fundamental","pubTime":"2025-02-05 14:58","pubTimestamp":1738738702,"startTime":"0","endTime":"0","summary":"An announcement from YUKIGUNI MAITAKE CO., LTD. ( ($JP:1375) ) is now available. Yukiguni Maitake Co., Ltd. is launching a new product line called ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/yukiguni-maitake-launches-mushroom-meat-to-tackle-protein-crisis?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/yukiguni-maitake-launches-mushroom-meat-to-tackle-protein-crisis?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ABVC"],"gpt_icon":0},{"id":"2507363590","title":"NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2507363590","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507363590?lang=en_us&edition=fundamental","pubTime":"2025-01-29 21:31","pubTimestamp":1738157460,"startTime":"0","endTime":"0","summary":"Advancing mental health treatment through innovative research, offering insights on symptom improvement and clinical tools. “NeuroStar is committed to advancing the body of scientific research and elevating mental health treatment through robust research and data-driven innovation,” stated Keith J. Sullivan, President and CEO of Neuronetics. “These findings not only reinforce TMS’s powerful ability to improve many symptoms people with depression face, but also provide clinicians with insights on common tools so they can deliver more precise and effective care. These publications further cement NeuroStar’s position as the leader in advancing TMS therapy and shaping the future of depression treatment.”The Profile of Symptom Change with Transcranial Magnetic Stimulation for Major Depressive Disorder. Comparison of the PHQ-9 and the QIDS-SR in Assessing the Antidepressant Effects of Transcranial Magnetic Stimulation: Sensitivity to Change","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neurostar-unveils-two-significant-publications-133100585.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ABVC","BK4139","STIM","BK4082"],"gpt_icon":0},{"id":"2506515284","title":"Neurocrine initiates Phase 3 registrational program for osavampator in MDD","url":"https://stock-news.laohu8.com/highlight/detail?id=2506515284","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506515284?lang=en_us&edition=fundamental","pubTime":"2025-01-28 21:36","pubTimestamp":1738071373,"startTime":"0","endTime":"0","summary":"Neurocrine (NBIX) initiated a Phase 3 registrational study to evaluate the efficacy, safety and tolerability of osavampator, an investigational dru...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurocrine-initiates-phase-3-registrational-program-for-osavampator-in-mdd?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurocrine-initiates-phase-3-registrational-program-for-osavampator-in-mdd?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0823416689.USD","LU2065171402.SGD","ABVC","BK4139","LU0109394709.USD","LU2065170008.USD","LU0889565916.HKD","LU2065169927.USD","LU2065171311.SGD","LU2324357040.USD","LU0320765992.SGD","NBIX"],"gpt_icon":0},{"id":"2506308527","title":"Supernus Pharmaceuticals Says US FDA Approves Label Update for ADHD Treatment Qelbree","url":"https://stock-news.laohu8.com/highlight/detail?id=2506308527","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506308527?lang=en_us&edition=fundamental","pubTime":"2025-01-27 22:35","pubTimestamp":1737988518,"startTime":"0","endTime":"0","summary":"Supernus Pharmaceuticals (SUPN) said Monday the US Food and Drug Administration has cleared a label update for qelbree, a treatment for attention-deficit/hyperactivity disorder, or ADHD.The updated la","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ADHD","SUPN","BK4007","BK4139","ABVC"],"gpt_icon":0},{"id":"2506743963","title":"Supernus Announces Label Update for Non-Stimulant ADHD Treatment, Qelbree®, Including New Pharmacodynamic Data and Information for Breastfeeding Women","url":"https://stock-news.laohu8.com/highlight/detail?id=2506743963","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506743963?lang=en_us&edition=fundamental","pubTime":"2025-01-27 21:00","pubTimestamp":1737982800,"startTime":"0","endTime":"0","summary":"Updated label includes new data in Section 12.2, detailing serotonin 5-HT2C partial agonist activity and norepinephrine transporter inhibition, highlighting Qelbree’s multimodal pharmacodynamics. Qelbree is the first ADHD treatment to meet its post marketing requirement and receive labeling approval following the 2019 FDA guidance on Clinical Lactation Studies1. The update to include lactation data in the label  follows the 2019 FDA guidance suggesting lactation studies be conducted to inform breastfeeding with drug use recommendations and is based on a study involving 15 healthy lactating women.The study evaluated the secretion of viloxazine and its metabolite  into breast milk following a multi-dose  regimen of viloxazine. Results showed that the estimated daily infant dose  of viloxazine and 5-HVLX-gluc was 0.085 mg/kg and 0.00595 mg/kg, respectively, and the relative infant dose was approximately 1% and 0.07%, respectively, of the weight-normalized maternal daily dose  of viloxazin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/supernus-announces-label-non-stimulant-130000268.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4023","BK4007","BK4135","SUPN","LU1169589451.USD","LU1169590202.USD","ADHD","ABVC","BK4139","PD","BK4134","III","CNS"],"gpt_icon":0},{"id":"2505404685","title":"People with ADHD are more likely to die early, according to a new study","url":"https://stock-news.laohu8.com/highlight/detail?id=2505404685","media":"businessinsider.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505404685?lang=en_us&edition=fundamental","pubTime":"2025-01-24 00:03","pubTimestamp":1737648189,"startTime":"0","endTime":"0","summary":"A new study found that people with ADHD likely have a shorter life expectancy.Men died about seven years earlier and women died nine years sooner than their peers.ADHD is linked to more impulsive or d","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.businessinsider.com/people-with-adhd-likely-to-die-earlier-new-study-2025-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"businsider_highlight","symbols":["ABVC","BK4139","ADHD"],"gpt_icon":0},{"id":"2505220294","title":"SPRAVATO® (esketamine) approved in the U.S. as the first and only monotherapy for adults with treatment-resistant depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2505220294","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505220294?lang=en_us&edition=fundamental","pubTime":"2025-01-21 21:00","pubTimestamp":1737464400,"startTime":"0","endTime":"0","summary":"Following U.S. FDA Priority Review, approval is based on data demonstrating SPRAVATO alone met its primary endpoint at 4 weeks and led to rapid and superior improvement in depressive symptoms compared to placebo as early as 24 hours1. SPRAVATO alone showed a rapid and superior improvement vs. placebo in the Montgomery-Asberg Depression Rating Scale  total score, with numerical improvements across all 10 MADRS items seen at day 28 in a post-hoc analysis2. TITUSVILLE, N.J., Jan. 21, 2025 /PRNewswire/ --Johnson & Johnson  announced today the U.S. Food and Drug Administration  approval of a supplemental New Drug Application  for SPRAVATO  CIII nasal spray, making this innovative treatment the first and only monotherapy for adults living with major depressive disorder  who have had an inadequate response to at least two oral antidepressants.Because of the risks of serious adverse outcomes resulting from sedation, dissociation, respiratory depression, abuse, and misuse, to facilitate safe an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/spravato-esketamine-approved-u-first-130000473.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/spravato-esketamine-approved-u-first-130000473.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4581","LU1929549753.HKD","IE00B3PB1722.GBP","IE00B7SZLL34.SGD","CNS","LU0098860793.USD","LU1674673691.USD","LU1280957306.USD","LU1585245621.USD","ABVC","LU0466842654.USD","BK4559","BK4568","LU0345770308.USD","SG9999002232.USD","BK4588","LU1244550494.USD","LU2112291526.USD","BK4533","LU1066053197.SGD","LU1221951046.USD","IE00BDGV0183.EUR","IE0034235303.USD","LU1162221912.USD","BK4534","BK4504","LU0234572021.USD","IE0002270589.USD","LU0889566641.SGD","LU1032955483.USD","IE00B2B36J28.USD","LU1023059063.AUD","LU1244550577.SGD","LU0234570918.USD","IE00B19Z3B42.SGD","LU1894683348.USD","BK4592","LU1914381329.SGD","IE00BJJMRZ35.SGD","LU1244550221.USD","IE000M9KFDE8.USD","LU1732800096.USD","SG9999001440.SGD","LU0345769128.USD","LU1778281490.HKD","IE00BJT1NW94.SGD","LU1718418525.SGD","JNJ","BK4532","BK4007"],"gpt_icon":0},{"id":"2505282065","title":"Weekly Roundup on the Cannabis Sector & Psychedelic Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=2505282065","media":"Market Exclusive","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505282065?lang=en_us&edition=fundamental","pubTime":"2025-01-20 23:48","pubTimestamp":1737388136,"startTime":"0","endTime":"0","summary":"Ascend Wellness secured $15 million to boost growth. Leafly Holdings transitioned to OTC trading after Nasdaq delisting. High Tide expanded into Germany with strategic acquisition. MindMed provided investor update with detailed plans for 2025 and beyond. Awakn secured unsecured credit facility to support research and development. Below is a weekly roundup of what happened this week in the cannabis and psychedelic sectors. In this ever-evolving landscape, we explore the major developments and groundbreaking initiatives happening among companies operating in these industries; from advancements in medical research, therapeutic applications to shifts in legal frameworks and current market trends.Cannabis multistate operator Ascend Wellness Holdings, Inc.   closed a $15 million private placement of senior secured notes, reinforcing its commitment to growth amid challenging market conditions. The notes, which were issued at 97% of their face value, carry a 12.75% interest rate and mature in ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/weekly-roundup-cannabis-sector-psychedelic-154856336.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TQQQ","BK4183","NVIW.SI","NQmain","SQQQ","HITI","PSQ","BK4547",".IXIC","USAW.SI","QLD","TSYW.SI","BK4007","MNMD","QID","USJW.SI","AAWH","ABVC","BK4139","MNQmain"],"gpt_icon":1},{"id":"2503992361","title":"ABVC BioPharma and AiBtl BioPharma's Worldwide Business Development Team Participate in the 43rd Annual J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2503992361","media":"NewMediaWire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503992361?lang=en_us&edition=fundamental","pubTime":"2025-01-16 21:30","pubTimestamp":1737034200,"startTime":"0","endTime":"0","summary":"The prestigious event, held annually in San Francisco, is a premier platform for global leaders in the healthcare and biotech sectors to connect, collaborate, and explore innovative partnerships. The BD Team will represent ABVC BioPharma and its subsidiaries at the conference. The team will share insights into the group's achievements, strategic direction, and exciting prospects for the future.\"As ABVC continues to grow and expand its pipeline, the J.P. Morgan Healthcare Conference presents a valuable opportunity to engage with partners who share our vision of improving healthcare outcomes,\" said Chairman & CBO Eugene Jiang. \"We are eager to discuss potential collaborations that we believe can accelerate our mission to bring life-changing therapies to market. We will also take the opportunity to share insights into ABVC's strategic collaborations with AiBtl BioPharma, ForSeeCon, and OncoX, highlighting the collective efforts driving innovation and growth across the group's core therape","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/abvc-biopharma-aibtl-biopharmas-worldwide-133000187.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4022","BK4120","HCSG","ABVC","BK4139","R","BK4232","BK4137","TISI"],"gpt_icon":1},{"id":"2503641133","title":"ABVC BioPharma s ADHD and MDD Drug Polygala Tenuifolia a Natural Wonder With Potential of Transforming Mental Health Treatment of More Than 30 Billion Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2503641133","media":"NewMediaWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503641133?lang=en_us&edition=fundamental","pubTime":"2025-01-15 21:30","pubTimestamp":1736947800,"startTime":"0","endTime":"0","summary":"Polygala tenuifolia, or Yuan Zhi, has long been utilized in traditional Chinese medicine to improve cognitive function and mental clarity. Its root contains bioactive compounds like polygala saponins and xanthones, which exhibit neuroprotective and anxiolytic properties. Studies reveal that these compounds modulate the dopaminergic and serotonergic pathways, offering therapeutic potential for mood disorders and ADHD.[2] Additionally, its antioxidant properties enhance neuroplasticity, making it a promising candidate for holistic mental health care.[3]. ABVC BioPharma has harnessed the therapeutic potential of Polygala tenuifolia in its proprietary PDC-1421 formulation. Recent internal clinical trials underscore the efficacy and safety of PDC-1421 in treating ADHD and MDD, addressing our perceived growing demand for natural, plant-based alternatives to synthetic drugs.MDD Treatment :PDC-1421 achieved a MontgomeryAsberg Depression Rating Scale  score reduction of -13.21 from baseline ove","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/abvc-biopharma-adhd-mdd-drug-133000095.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","PP","BK4232","ITT","R","BK4161","BK4022","ABVC","LU0053671581.USD","ADHD","LU0054578231.USD"],"gpt_icon":0},{"id":"2503653570","title":"Intra-Cellular Therapies Stock Up 34% on J&J's $14.6B Buyout Offer","url":"https://stock-news.laohu8.com/highlight/detail?id=2503653570","media":"Zacks","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503653570?lang=en_us&edition=fundamental","pubTime":"2025-01-14 21:54","pubTimestamp":1736862840,"startTime":"0","endTime":"0","summary":"Intra-Cellular Therapies ITCI signed a definitive agreement with pharma bigwig Johnson & Johnson JNJ. Per the terms, the pharma giant will acquire all outstanding shares of ITCI for $132 per share in cash, aggregating to nearly $14.6 billion.A commercial-stage biotech company, Intra-Cellular is focused on developing and marketing novel drugs targeting neuropsychiatric and neurological disorders.The acquisition will add ITCI’s sole marketed drug, Caplyta, which is approved for two indications — schizophrenia and bipolar depression. A regulatory filing was submitted to the FDA last month seeking label expansion for this oral therapy in the major depressive disorder  indication.ITCI is also developing its pipeline candidate ITI-1284 for multiple indications — generalized anxiety disorder, and Alzheimer's disease-related psychosis and agitation — across several mid-stage programs. Post the acquisition, J&J will add this investigational drug to its pipeline.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/intra-cellular-therapies-stock-34-135400738.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ITCI","LU1066051498.USD","LU0053671581.USD","BK4581","IE00BGHQF631.EUR","LU1261432733.SGD","SG9999002224.SGD","LU1732800096.USD","SDZNY","LU0889565916.HKD","BK4007","LU0912757837.SGD","BK4533","LU1032466523.USD","LU1674673428.USD","IE00B19Z3B42.SGD","IE00BFTCPJ56.SGD","LU0098860793.USD","IE00B1BXHZ80.USD","LU0109394709.USD","LU1059921491.USD","LU0289739699.SGD","LU1506573853.SGD","LU1914381329.SGD","LU2089984988.USD","IE00B3PB1722.GBP","LU1221951129.SGD","LU0882574055.USD","LU1032955483.USD","LU0320765646.SGD","IE00B2B36J28.USD","LU0792757196.USD","IE00BJT1NW94.SGD","LU2602419157.SGD","LU1718418525.SGD","LU0889566641.SGD","LU1066053197.SGD","ABVC","LU1732799900.SGD","LU0058720904.USD","LU0122379950.USD","LU0012050646.USD","LU0795875169.SGD","JNJ","IE00BVYPNV92.GBP","BK4568","LU1057294990.SGD","LU1162221912.USD","LU1894683264.USD","LU0640476718.USD"],"gpt_icon":0},{"id":"2503755576","title":"AiBtl BioPharma Strengthens Partnership With ABVC BioPharma, Paying $150,000 in Licensing Fees","url":"https://stock-news.laohu8.com/highlight/detail?id=2503755576","media":"NewMediaWire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503755576?lang=en_us&edition=fundamental","pubTime":"2025-01-14 21:30","pubTimestamp":1736861400,"startTime":"0","endTime":"0","summary":"Licensing Fees From AiBtl and Strategic Partners Now Total $696,000, Bolstering Confidence in AiBtl's Plans. These incremental licensing fees highlight AiBtl's commitment to ABVC's innovative biopharma pipeline and reinforce this partnership's strategic benefits. AiBtl is focused on developing cutting-edge natural therapies that it believes can create long-term value for its investors and stakeholders.\"This milestone represents another step in AiBtl's growth journey,\" said Russ Jaimes, CEO of AiBtl BioPharma. \"With the continued support of ABVC and our strategic partners, we are well-positioned to execute our growth plans and expand our market presence.\". ABVC BioPharma is strategically positioned in growing markets. The global MDD market is projected to grow from $11.51 billion in 2022 to $14.96 billion by 2032, with a steady CAGR of 2.8%.[1] The global ADHD treatment market is also growing, expected to increase from $15.23 billion in 2022 at a CAGR of 7.3% through 2032.[2] Additional","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aibtl-biopharma-strengthens-partnership-abvc-133000542.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ABVC","R","ADHD","BK4232","BK4022","BK4139"],"gpt_icon":0},{"id":"2503555448","title":"Biogen Offers to Buy Remaining Stake in Sage Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2503555448","media":"Zacks","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503555448?lang=en_us&edition=fundamental","pubTime":"2025-01-14 04:00","pubTimestamp":1736798400,"startTime":"0","endTime":"0","summary":"Sage Therapeutics  said Biogen  has made an unsolicited offer to acquire the rest of SAGE shares.Biogen currently owns a 10.2% stake in Sage Therapeutics; SAGE board members will review the offer.Sage Therapeutics SAGE announced that its partner Biogen BIIB has made an unsolicited, non-binding proposal offer to acquire the SAGE shares that it does not already own for $7.22per share. The offer price represents a premium of 30% on Sage Therapeutics’ closing price of $5.55 on Friday.At present, Biogen owns a 10.2% stake in SAGE, per a SEC filing by the company. Sage Therapeutics’ board will review and evaluate the offer and will come to a final decision.SAGE’s stock was up 46% in after-hours trading on Friday in response to the news while Biogen was down slightly.Biogen’s shares have declined 40%, while Sage Therapeutics’ stock has been down 79.1% in the past year, compared with a decrease of 15.9% for the industry.In September, Biogen terminated its rights under the collaboration and lic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biogen-offers-buy-remaining-stake-200000531.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4581","CSTL","BK4139","BK4530","LU0109394709.USD","LU0889565916.HKD","IE00B19Z9Z06.USD","ET","PBYI","BK4585","BK4561","IE00B19Z9P08.USD","BK4590","LU0320765992.SGD","BK4121","ABVC","SAGE","LU0234570918.USD","BK4144","BK4532","BK4533","BIIB","IE00B894F039.SGD","PPD","MCI","BK4196","BK4588"],"gpt_icon":0},{"id":"2503958955","title":"ABVC BioPharma, Inc. Granted Additional 180-Day Grace Period to Regain Compliance With Nasdaq Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2503958955","media":"NewMediaWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503958955?lang=en_us&edition=fundamental","pubTime":"2025-01-13 22:00","pubTimestamp":1736776800,"startTime":"0","endTime":"0","summary":"ABVC remains fully committed to addressing the bid price deficiency during this extended compliance period. If the Company's closing bid price meets or exceeds $1 per share for a minimum of 10 consecutive business days within this timeframe, we will be in compliance with that requirement and Nasdaq should close this matter.The Company has demonstrated compliance with all other applicable Nasdaq continued listing requirements, including the market value of publicly held shares and shareholder equity thresholds.To ensure compliance, ABVC intends to monitor its stock price closely and will take all necessary steps to maintain its Nasdaq listing.Uttam Patil, Ph.D., Chief Executive Officer of ABVC, stated: \"We appreciate Nasdaq's confidence in our ability to achieve compliance. This extension provides the flexibility needed to implement strategic measures that are expected to enhance shareholder value and maintain our position on the Nasdaq. We remain optimistic about achieving compliance a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/abvc-biopharma-inc-granted-additional-140000540.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","NQmain","IE00BGHQF748.EUR","MNQmain","BK4232","IE00B3QW5Z07.USD","BK4022","NVIW.SI","TSYW.SI","SQQQ","NDAQ","PSQ","QID",".IXIC","QLD","BK4112","R","LU2095319765.USD","BK4585","ABVC","LU2210149790.SGD","USJW.SI","IE00BKPKM429.USD","USAW.SI","BK4139","IE00B64PRP62.GBP","TQQQ","LU2210150020.SGD"],"gpt_icon":1},{"id":"2503025553","title":"Xenon Outlines Key Corporate Milestone Opportunities for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2503025553","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503025553?lang=en_us&edition=fundamental","pubTime":"2025-01-13 21:30","pubTimestamp":1736775000,"startTime":"0","endTime":"0","summary":"– Topline data from the first Phase 3 FOS study anticipated in H2 2025 representing major milestone in support of NDA filing and potential launch of azetukalner – First of three planned Phase 3 MDD st","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/13/3008537/33485/en/Xenon-Outlines-Key-Corporate-Milestone-Opportunities-for-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","DBP","LU0300736062.USD","LU0170899867.USD","LU0266512127.USD","BK4138","LU0122376428.USD","ABVC","LU0368265418.SGD","LU0456854461.SGD","LU0300736492.USD","LU0788109394.HKD","MPC","IE00BSNM7G36.USD","BK4139","BK4588"],"gpt_icon":0},{"id":"2503094523","title":"Press Release: Neuronetics Provides Business Update and Issues 2025 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2503094523","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503094523?lang=en_us&edition=fundamental","pubTime":"2025-01-13 21:00","pubTimestamp":1736773200,"startTime":"0","endTime":"0","summary":"-- Preliminary unaudited fourth quarter and full year revenue 2024 was $22.1. -- Expects full year 2025 pro forma year-over-year revenue growth of 12% -. -- Expects to realize over $22 million in annualized cost synergies. -- Expects to achieve cash flow breakeven in the third quarter of 2025. MALVERN, Pa., Jan. 13, 2025  -- Neuronetics, Inc.   today announced preliminary fourth quarter and full year 2024 revenue and issued 2025 financial guidance.Preliminary Fourth Quarter and Full Year 2024 Results. Neuronetics' preliminary unaudited fourth quarter and full year revenue 2024 was $22.1 and $74.5, respectively. These results reflect Neuronetics' standalone performance through December 10, 2024, and combined performance with Greenbrook TMS for the remainder of the year. In the quarter, the Company shipped 50 systems.Preliminary Proforma Fourth Quarter and Full Year 2024 Results. This 4Q 2024 presentation assumes the acquisition between Greenbrook and Neuronetics occurred on October 1, 2","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","STIM","ABVC","BK4082","BK4139","BK4022","BK4232"],"gpt_icon":0},{"id":"2503309108","title":"Cybin Highlights 2024 Accomplishments and Upcoming Milestones for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2503309108","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503309108?lang=en_us&edition=fundamental","pubTime":"2025-01-13 20:30","pubTimestamp":1736771400,"startTime":"0","endTime":"0","summary":"- Announced positive Phase 2 Data for CYB003, Demonstrating Breakthrough 12-Month Efficacy in Treating Major Depressive Disorder  -. - Initiated PARADIGM: A Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of MDD –。- Received U.S. Food and Drug Administration  Breakthrough Therapy Designation  for CYB003 for the Adjunctive Treatment of MDD -. - Topline efficacy data from Phase 2 Proof-of-Concept Study of CYB004 in Generalized Anxiety Disorder  expected in Q1 2025 -. TORONTO, January 13, 2025----Cybin Inc.   , a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, is pleased to provide a year-end summary of its key accomplishments in 2024 and upcoming milestones for 2025.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cybin-highlights-2024-accomplishments-upcoming-123000251.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4168","ABVC","BK4007","CYBN"],"gpt_icon":0},{"id":"2501200928","title":"ABVC BioPharma and ForSeeCon: An Update on Alliance's Ophthalmology-Related Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2501200928","media":"NewMediaWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501200928?lang=en_us&edition=fundamental","pubTime":"2025-01-07 21:30","pubTimestamp":1736256600,"startTime":"0","endTime":"0","summary":"Revolutionary Patented Technology Poised to Address Unmet Medical Needs in a Transformative $4.3 Billion Market Opportunity. Vitargus is the world's first one-of-a-kind biodegradable hydrogel vitreous substitute with a unique combination of properties that our internal clinical studies have shown to enhance retinal reattachment surgery. Derived from hyaluronic acid, a natural substance in the human body, we believe that Vitargus provides superior visual and structural support, making it a game-changer in vitreoretinal surgery. ABVC BioPharma has a strategic licensing agreement with ForSeeCon Eye Corporation , a company known for its dedication to advancing ophthalmology. FEYE's interest in innovative solutions for retinal diseases aligns with ABVC BioPharma's commitment to addressing unmet needs in the field. The collaboration focuses on Vitargus and has a potential deal value of $187 million, including milestone payments and future royalties. FEYE's expertise in the ophthalmology mark","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/abvc-biopharma-forseecon-alliances-ophthalmology-133000646.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["R","BK4139","BK4022","BK4232","ABVC"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":90,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ABVC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-04-30","symbol":"ABVC","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1745985600000,"reportTimeType":"post","actualEps":-0.06},{"market":"US","date":"2025-04-15","symbol":"ABVC","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1744689600000,"reportTimeType":"post","actualEps":0.04},{"market":"US","date":"2024-11-14","symbol":"ABVC","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"pre","actualEps":-0.02},{"market":"US","date":"2024-08-14","symbol":"ABVC","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"","actualEps":-0.09},{"market":"US","date":"2024-05-17","symbol":"ABVC","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715918400000,"reportTimeType":"post","actualEps":-0.4}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ABVC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ABVC\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ABVC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ABVC","date":"2025-06-13","current":-10.328685,"percent":0.243506,"low":-22.659095,"twenty":-11.690443,"median":-1.615552,"eighty":-0.794817,"high":-0.260274,"avg":-5.517963,"sd":5.90537,"marketCap":30064261},"quantilePoints":[{"date":"2020-06-19","current":-15.563236,"twenty":-104.984049,"median":-70.569383,"eighty":-16.368319,"marketCap":56677821},{"date":"2020-06-26","current":-15.563236,"twenty":-104.984049,"median":-70.569383,"eighty":-15.82702,"marketCap":56677821},{"date":"2020-07-02","current":-14.066248,"twenty":-104.984049,"median":-70.569383,"eighty":-15.82702,"marketCap":57638463},{"date":"2020-07-10","current":-14.066248,"twenty":-104.984049,"median":-70.569383,"eighty":-15.82702,"marketCap":57638463},{"date":"2020-07-17","current":-15.472873,"twenty":-104.984049,"median":-70.569383,"eighty":-15.731773,"marketCap":63402309},{"date":"2020-07-24","current":-17.58281,"twenty":-104.984049,"median":-64.954263,"eighty":-15.762085,"marketCap":72048078},{"date":"2020-07-31","current":-18.52056,"twenty":-104.984049,"median":-64.198981,"eighty":-15.771827,"marketCap":75890642},{"date":"2020-08-07","current":-17.817247,"twenty":-104.984049,"median":-60.422571,"eighty":-15.816469,"marketCap":73008719},{"date":"2020-08-14","current":-14.118204,"twenty":-104.984049,"median":-58.912006,"eighty":-15.816469,"marketCap":76088142},{"date":"2020-08-21","current":-14.296916,"twenty":-104.984049,"median":-47.962314,"eighty":-15.601069,"marketCap":77051284},{"date":"2020-08-28","current":-12.867224,"twenty":-104.984049,"median":-47.962314,"eighty":-15.563236,"marketCap":69346155},{"date":"2020-09-04","current":-14.296916,"twenty":-104.984049,"median":-47.962314,"eighty":-15.563236,"marketCap":77051284},{"date":"2020-09-11","current":-14.118204,"twenty":-104.984049,"median":-47.962314,"eighty":-15.563236,"marketCap":76088142},{"date":"2020-09-18","current":-14.296916,"twenty":-104.984049,"median":-47.962314,"eighty":-15.563236,"marketCap":77051284},{"date":"2020-09-25","current":-14.118204,"twenty":-104.984049,"median":-47.962314,"eighty":-15.299453,"marketCap":76088142},{"date":"2020-10-02","current":-14.654339,"twenty":-104.984049,"median":-47.962314,"eighty":-14.943492,"marketCap":78977566},{"date":"2020-10-09","current":-14.887513,"twenty":-104.984049,"median":-47.962314,"eighty":-14.873601,"marketCap":80234224},{"date":"2020-10-16","current":-15.910707,"twenty":-104.984049,"median":-47.962314,"eighty":-14.887513,"marketCap":85748593},{"date":"2020-10-23","current":-15.522641,"twenty":-104.984049,"median":-47.962314,"eighty":-14.957404,"marketCap":83657164},{"date":"2020-10-30","current":-15.134575,"twenty":-104.984049,"median":-46.033619,"eighty":-15.082344,"marketCap":81565734},{"date":"2020-11-06","current":-15.199238,"twenty":-104.984049,"median":-46.033619,"eighty":-15.134575,"marketCap":81914224},{"date":"2020-11-13","current":-15.009247,"twenty":-104.984049,"median":-43.698955,"eighty":-14.957404,"marketCap":80890296},{"date":"2020-11-20","current":-13.64563,"twenty":-104.984049,"median":-39.895803,"eighty":-14.839343,"marketCap":82154224},{"date":"2020-11-27","current":-14.327911,"twenty":-104.984049,"median":-39.895803,"eighty":-14.654339,"marketCap":86261935},{"date":"2020-12-04","current":-14.498482,"twenty":-104.984049,"median":-39.895803,"eighty":-14.484769,"marketCap":87288863},{"date":"2020-12-11","current":-15.351334,"twenty":-104.984049,"median":-38.369814,"eighty":-14.475627,"marketCap":92423502},{"date":"2020-12-18","current":-17.057037,"twenty":-104.984049,"median":-37.594122,"eighty":-14.484769,"marketCap":102692780},{"date":"2020-12-24","current":-17.739319,"twenty":-104.984049,"median":-36.826895,"eighty":-14.498482,"marketCap":106800491},{"date":"2020-12-31","current":-17.398178,"twenty":-104.984049,"median":-36.826895,"eighty":-14.498482,"marketCap":104746635},{"date":"2021-01-08","current":-20.052297,"twenty":-104.984049,"median":-36.67345,"eighty":-14.549617,"marketCap":120725895},{"date":"2021-01-15","current":-21.65648,"twenty":-104.984049,"median":-34.580924,"eighty":-14.654339,"marketCap":130383966},{"date":"2021-01-22","current":-21.255434,"twenty":-104.984049,"median":-33.757987,"eighty":-14.654339,"marketCap":127969448},{"date":"2021-01-29","current":-20.052297,"twenty":-104.984049,"median":-33.757987,"eighty":-14.666109,"marketCap":120725895},{"date":"2021-02-05","current":-19.851774,"twenty":-104.984049,"median":-33.757987,"eighty":-14.751318,"marketCap":119518636},{"date":"2021-02-12","current":-19.450728,"twenty":-104.984049,"median":-32.897231,"eighty":-14.809783,"marketCap":117104118},{"date":"2021-02-19","current":-20.052297,"twenty":-104.984049,"median":-32.897231,"eighty":-14.839343,"marketCap":120725895},{"date":"2021-02-26","current":-17.646021,"twenty":-104.984049,"median":-32.530424,"eighty":-14.873601,"marketCap":106238787},{"date":"2021-03-05","current":-17.646021,"twenty":-104.984049,"median":-31.609752,"eighty":-14.887513,"marketCap":106238787},{"date":"2021-03-12","current":-18.047067,"twenty":-104.984049,"median":-30.689079,"eighty":-14.920184,"marketCap":108653305},{"date":"2021-03-19","current":-10.850476,"twenty":-104.984049,"median":-30.689079,"eighty":-14.839343,"marketCap":106238787},{"date":"2021-03-26","current":-10.973777,"twenty":-104.984049,"median":-30.437981,"eighty":-14.654339,"marketCap":107446046},{"date":"2021-04-01","current":-11.097077,"twenty":-104.984049,"median":-30.103498,"eighty":-14.498482,"marketCap":108653305},{"date":"2021-04-09","current":-10.850476,"twenty":-104.984049,"median":-30.103498,"eighty":-14.386997,"marketCap":106238787},{"date":"2021-04-16","current":-10.850476,"twenty":-104.984049,"median":-29.613533,"eighty":-14.327911,"marketCap":106238787},{"date":"2021-04-23","current":-11.097077,"twenty":-104.984049,"median":-28.765565,"eighty":-14.296916,"marketCap":108653305},{"date":"2021-04-30","current":-11.097077,"twenty":-104.984049,"median":-28.224507,"eighty":-14.296916,"marketCap":108653305},{"date":"2021-05-07","current":-11.46698,"twenty":-104.984049,"median":-28.224507,"eighty":-14.296916,"marketCap":112275082},{"date":"2021-05-14","current":-13.730013,"twenty":-104.984049,"median":-27.28369,"eighty":-14.296916,"marketCap":132798484},{"date":"2021-05-21","current":-13.730013,"twenty":-104.984049,"median":-26.65832,"eighty":-14.296916,"marketCap":132798484},{"date":"2021-05-28","current":-13.730013,"twenty":-103.326706,"median":-26.132665,"eighty":-14.118204,"marketCap":132798484},{"date":"2021-06-04","current":-13.355558,"twenty":-100.840692,"median":-25.838836,"eighty":-14.118204,"marketCap":129176707},{"date":"2021-06-11","current":-12.981103,"twenty":-100.840692,"median":-25.62158,"eighty":-14.066248,"marketCap":125554930},{"date":"2021-06-18","current":-11.857738,"twenty":-100.840692,"median":-25.489795,"eighty":-14.066248,"marketCap":114689600},{"date":"2021-06-25","current":-12.48183,"twenty":-100.840692,"median":-23.923098,"eighty":-13.947524,"marketCap":120725895},{"date":"2021-07-02","current":-11.233647,"twenty":-100.840692,"median":-23.282,"eighty":-13.770344,"marketCap":108653305},{"date":"2021-07-09","current":-12.48183,"twenty":-100.840692,"median":-22.944579,"eighty":-13.730013,"marketCap":120725895},{"date":"2021-07-16","current":-12.48183,"twenty":-100.840692,"median":-22.775869,"eighty":-13.730013,"marketCap":120725895},{"date":"2021-07-23","current":-12.357012,"twenty":-100.840692,"median":-22.633127,"eighty":-13.64563,"marketCap":119518636},{"date":"2021-07-30","current":-12.357585,"twenty":-100.840692,"median":-22.438449,"eighty":-13.64563,"marketCap":119524184},{"date":"2021-08-06","current":-8.290388,"twenty":-100.840692,"median":-22.020758,"eighty":-13.355558,"marketCap":80185717},{"date":"2021-08-13","current":-5.99167,"twenty":-100.840692,"median":-21.65648,"eighty":-13.337149,"marketCap":58684815},{"date":"2021-08-20","current":-5.242711,"twenty":-100.840692,"median":-21.054911,"eighty":-13.23074,"marketCap":51349213},{"date":"2021-08-27","current":-7.670371,"twenty":-100.840692,"median":-20.611957,"eighty":-13.105921,"marketCap":75126681},{"date":"2021-09-03","current":-8.393504,"twenty":-100.840692,"median":-20.536178,"eighty":-12.981103,"marketCap":82209331},{"date":"2021-09-10","current":-8.290199,"twenty":-100.840692,"median":-20.327641,"eighty":-12.731467,"marketCap":81197524},{"date":"2021-09-17","current":-7.386283,"twenty":-100.840692,"median":-20.25282,"eighty":-12.48183,"marketCap":72344211},{"date":"2021-09-24","current":-6.404889,"twenty":-100.840692,"median":-20.249018,"eighty":-12.48183,"marketCap":62732043},{"date":"2021-10-01","current":-5.862539,"twenty":-100.840692,"median":-20.143991,"eighty":-12.48183,"marketCap":57420056},{"date":"2021-10-08","current":-5.578452,"twenty":-96.807064,"median":-20.052297,"eighty":-12.48183,"marketCap":54637586},{"date":"2021-10-15","current":-6.998891,"twenty":-95.798657,"median":-20.052297,"eighty":-12.48183,"marketCap":68549935},{"date":"2021-10-22","current":-6.379063,"twenty":-95.798657,"median":-20.02901,"eighty":-12.357012,"marketCap":62479092},{"date":"2021-10-29","current":-6.885086,"twenty":-95.798657,"median":-20.005723,"eighty":-12.332048,"marketCap":67435282},{"date":"2021-11-05","current":-10.164989,"twenty":-93.770452,"median":-19.95676,"eighty":-12.112235,"marketCap":99559965},{"date":"2021-11-12","current":-8.999403,"twenty":-93.263401,"median":-19.851774,"eighty":-11.72383,"marketCap":88143755},{"date":"2021-11-19","current":-9.556177,"twenty":-93.263401,"median":-19.851774,"eighty":-11.230993,"marketCap":93218994},{"date":"2021-11-26","current":-9.294762,"twenty":-93.263401,"median":-19.851774,"eighty":-11.139591,"marketCap":90668931},{"date":"2021-12-03","current":-8.510516,"twenty":-93.263401,"median":-19.450728,"eighty":-11.097077,"marketCap":83018740},{"date":"2021-12-10","current":-10.108053,"twenty":-90.465498,"median":-19.450728,"eighty":-11.097077,"marketCap":98602462},{"date":"2021-12-17","current":-10.398515,"twenty":-88.60023,"median":-19.450728,"eighty":-11.097077,"marketCap":101435866},{"date":"2021-12-23","current":-10.950391,"twenty":-88.60023,"median":-19.250205,"eighty":-11.042884,"marketCap":106819334},{"date":"2021-12-31","current":-9.846638,"twenty":-88.60023,"median":-18.803806,"eighty":-10.973777,"marketCap":96052398},{"date":"2022-01-07","current":-9.90473,"twenty":-88.60023,"median":-18.754997,"eighty":-10.850476,"marketCap":96619079},{"date":"2022-01-14","current":-9.556177,"twenty":-88.60023,"median":-18.687731,"eighty":-10.850476,"marketCap":93218994},{"date":"2022-01-21","current":-7.900547,"twenty":-88.60023,"median":-18.539338,"eighty":-10.850476,"marketCap":77068591},{"date":"2022-01-28","current":-7.174394,"twenty":-88.60023,"median":-18.52056,"eighty":-10.712213,"marketCap":69985081},{"date":"2022-02-04","current":-7.319625,"twenty":-88.60023,"median":-18.401426,"eighty":-10.554554,"marketCap":71401783},{"date":"2022-02-11","current":-7.668178,"twenty":-88.60023,"median":-18.286122,"eighty":-10.404324,"marketCap":74801868},{"date":"2022-02-18","current":-7.348671,"twenty":-88.60023,"median":-18.220695,"eighty":-10.343792,"marketCap":71685123},{"date":"2022-02-25","current":-7.116302,"twenty":-88.60023,"median":-18.188702,"eighty":-10.164989,"marketCap":69418400},{"date":"2022-03-04","current":-7.116302,"twenty":-88.60023,"median":-18.047067,"eighty":-9.98737,"marketCap":69418400},{"date":"2022-03-11","current":-6.622518,"twenty":-88.60023,"median":-18.047067,"eighty":-9.875684,"marketCap":64601613},{"date":"2022-03-18","current":-6.564425,"twenty":-88.60023,"median":-17.909889,"eighty":-9.788546,"marketCap":64034932},{"date":"2022-03-25","current":-7.029163,"twenty":-88.60023,"median":-17.850261,"eighty":-9.704796,"marketCap":68568379},{"date":"2022-04-01","current":-6.339112,"twenty":-88.60023,"median":-17.739319,"eighty":-9.704796,"marketCap":81386671},{"date":"2022-04-08","current":-6.31572,"twenty":-88.60023,"median":-17.732346,"eighty":-9.704796,"marketCap":81086351},{"date":"2022-04-14","current":-5.894672,"twenty":-88.60023,"median":-17.680293,"eighty":-9.60846,"marketCap":75680594},{"date":"2022-04-22","current":-5.754323,"twenty":-88.60023,"median":-17.646021,"eighty":-9.54452,"marketCap":73878675},{"date":"2022-04-29","current":-5.590582,"twenty":-88.60023,"median":-17.646021,"eighty":-9.360688,"marketCap":71776436},{"date":"2022-05-06","current":-5.766019,"twenty":-88.60023,"median":-17.646021,"eighty":-9.252091,"marketCap":74028835},{"date":"2022-05-13","current":-5.2631,"twenty":-88.60023,"median":-17.58281,"eighty":-9.119715,"marketCap":67571959},{"date":"2022-05-20","current":-3.799171,"twenty":-88.60023,"median":-17.545855,"eighty":-9.098246,"marketCap":67267162},{"date":"2022-05-27","current":-3.527801,"twenty":-88.60023,"median":-17.467267,"eighty":-9.097299,"marketCap":62462364},{"date":"2022-06-03","current":-3.744897,"twenty":-88.60023,"median":-17.373275,"eighty":-9.093511,"marketCap":66306202},{"date":"2022-06-10","current":-1.628216,"twenty":-88.60023,"median":-17.227608,"eighty":-8.989743,"marketCap":28828783},{"date":"2022-06-17","current":-1.764263,"twenty":-88.60023,"median":-17.146548,"eighty":-8.906096,"marketCap":31237588},{"date":"2022-06-24","current":-1.790857,"twenty":-88.60023,"median":-17.057037,"eighty":-8.85907,"marketCap":31708458},{"date":"2022-07-01","current":-1.82722,"twenty":-88.60023,"median":-17.057037,"eighty":-8.794971,"marketCap":32352301},{"date":"2022-07-08","current":-1.881494,"twenty":-88.60023,"median":-16.871014,"eighty":-8.794971,"marketCap":33313261},{"date":"2022-07-15","current":-1.415282,"twenty":-88.60023,"median":-16.641799,"eighty":-8.791309,"marketCap":25058619},{"date":"2022-07-22","current":-1.4189,"twenty":-88.60023,"median":-16.368319,"eighty":-8.790393,"marketCap":25122683},{"date":"2022-07-29","current":-1.175934,"twenty":-88.60023,"median":-16.201757,"eighty":-8.70552,"marketCap":20820788},{"date":"2022-08-05","current":-1.14735,"twenty":-88.60023,"median":-16.10474,"eighty":-8.638835,"marketCap":20314682},{"date":"2022-08-12","current":-1.212116,"twenty":-88.60023,"median":-15.910707,"eighty":-8.55118,"marketCap":21461427},{"date":"2022-08-19","current":-1.600085,"twenty":-88.60023,"median":-15.82702,"eighty":-8.491696,"marketCap":28150574},{"date":"2022-08-26","current":-1.546748,"twenty":-88.60023,"median":-15.82702,"eighty":-8.487276,"marketCap":27212221},{"date":"2022-09-02","current":-1.875961,"twenty":-88.60023,"median":-15.82702,"eighty":-8.487276,"marketCap":33004121},{"date":"2022-09-09","current":-2.023095,"twenty":-88.60023,"median":-15.82702,"eighty":-8.340059,"marketCap":35592680},{"date":"2022-09-16","current":-1.3426,"twenty":-88.60023,"median":-15.800641,"eighty":-8.303464,"marketCap":23620596},{"date":"2022-09-23","current":-1.680089,"twenty":-88.60023,"median":-15.762085,"eighty":-8.21272,"marketCap":29558103},{"date":"2022-09-30","current":-1.618476,"twenty":-88.60023,"median":-15.716674,"eighty":-8.036784,"marketCap":28474144},{"date":"2022-10-07","current":-1.626753,"twenty":-88.60023,"median":-15.610527,"eighty":-7.747849,"marketCap":28619750},{"date":"2022-10-14","current":-1.287424,"twenty":-88.60023,"median":-15.563236,"eighty":-7.670371,"marketCap":22649887},{"date":"2022-10-21","current":-1.324208,"twenty":-88.60023,"median":-15.563236,"eighty":-7.581872,"marketCap":23297027},{"date":"2022-10-28","current":-1.359888,"twenty":-88.60023,"median":-15.563236,"eighty":-7.479591,"marketCap":23924752},{"date":"2022-11-04","current":-1.348301,"twenty":-88.60023,"median":-15.563236,"eighty":-7.430234,"marketCap":23720903},{"date":"2022-11-11","current":-1.327151,"twenty":-88.60023,"median":-15.563236,"eighty":-7.386283,"marketCap":23348798},{"date":"2022-11-18","current":-1.231758,"twenty":-88.60023,"median":-15.563236,"eighty":-7.319625,"marketCap":24008880},{"date":"2022-11-25","current":-1.245038,"twenty":-88.60023,"median":-15.522641,"eighty":-7.302197,"marketCap":24267736},{"date":"2022-12-02","current":-1.269773,"twenty":-88.60023,"median":-15.497757,"eighty":-7.288183,"marketCap":24749855},{"date":"2022-12-09","current":-1.228438,"twenty":-88.60023,"median":-15.445794,"eighty":-7.272153,"marketCap":23944166},{"date":"2022-12-16","current":-1.162036,"twenty":-88.60023,"median":-15.329372,"eighty":-7.261532,"marketCap":22649887},{"date":"2022-12-23","current":-1.145435,"twenty":-88.60023,"median":-15.299453,"eighty":-7.226677,"marketCap":22326317},{"date":"2022-12-30","current":-1.037532,"twenty":-88.60023,"median":-15.199238,"eighty":-7.174394,"marketCap":20223113},{"date":"2023-01-06","current":-1.512141,"twenty":-88.133914,"median":-15.199238,"eighty":-7.100329,"marketCap":29473974},{"date":"2023-01-13","current":-1.435777,"twenty":-86.576754,"median":-15.134575,"eighty":-6.953369,"marketCap":27985521},{"date":"2023-01-20","current":-1.29484,"twenty":-85.538648,"median":-15.003998,"eighty":-6.821454,"marketCap":25238445},{"date":"2023-01-27","current":-1.261473,"twenty":-85.538648,"median":-14.852734,"eighty":-6.739858,"marketCap":24588070},{"date":"2023-02-03","current":-1.167182,"twenty":-85.538648,"median":-14.654339,"eighty":-6.646897,"marketCap":22750194},{"date":"2023-02-10","current":-1.245038,"twenty":-70.569383,"median":-14.475627,"eighty":-6.564425,"marketCap":24267736},{"date":"2023-02-17","current":-1.203539,"twenty":-70.569383,"median":-14.327911,"eighty":-6.471848,"marketCap":23458844},{"date":"2023-02-24","current":-1.161758,"twenty":-70.569383,"median":-14.296916,"eighty":-6.418638,"marketCap":22644477},{"date":"2023-03-03","current":-1.170116,"twenty":-70.569383,"median":-14.296916,"eighty":-6.368733,"marketCap":22807387},{"date":"2023-03-10","current":-0.98808,"twenty":-70.569383,"median":-14.296916,"eighty":-6.32741,"marketCap":19259209},{"date":"2023-03-17","current":-1.002957,"twenty":-70.569383,"median":-14.296916,"eighty":-6.222154,"marketCap":19549189},{"date":"2023-03-24","current":-1.019673,"twenty":-70.569383,"median":-14.118204,"eighty":-6.090777,"marketCap":19875009},{"date":"2023-03-31","current":-1.069821,"twenty":-70.569383,"median":-14.118204,"eighty":-5.965645,"marketCap":20852468},{"date":"2023-04-06","current":-1.043077,"twenty":-70.569383,"median":-14.066248,"eighty":-5.910288,"marketCap":20331189},{"date":"2023-04-14","current":-1.321345,"twenty":-64.954263,"median":-14.066248,"eighty":-5.744966,"marketCap":21700767},{"date":"2023-04-21","current":-1.310948,"twenty":-60.422571,"median":-13.83181,"eighty":-5.658826,"marketCap":21530015},{"date":"2023-04-28","current":-1.398249,"twenty":-47.962314,"median":-13.730013,"eighty":-5.59802,"marketCap":22963775},{"date":"2023-05-05","current":-1.498124,"twenty":-47.962314,"median":-13.705049,"eighty":-5.49939,"marketCap":24604044},{"date":"2023-05-12","current":-1.558049,"twenty":-47.962314,"median":-13.64563,"eighty":-5.24151,"marketCap":25588206},{"date":"2023-05-19","current":-1.963531,"twenty":-47.962314,"median":-13.355558,"eighty":-3.791935,"marketCap":24056194},{"date":"2023-05-26","current":-1.809834,"twenty":-47.962314,"median":-13.299333,"eighty":-3.683387,"marketCap":22173165},{"date":"2023-06-02","current":-1.797516,"twenty":-46.033619,"median":-13.23074,"eighty":-3.614639,"marketCap":22022260},{"date":"2023-06-09","current":-1.684251,"twenty":-43.485789,"median":-12.981103,"eighty":-3.299851,"marketCap":20634592},{"date":"2023-06-16","current":-1.609276,"twenty":-39.895803,"median":-12.731467,"eighty":-2.015739,"marketCap":19716041},{"date":"2023-06-23","current":-1.446742,"twenty":-38.369814,"median":-12.48183,"eighty":-1.965287,"marketCap":17724753},{"date":"2023-06-30","current":-1.344455,"twenty":-36.826895,"median":-12.48183,"eighty":-1.921295,"marketCap":16471587},{"date":"2023-07-07","current":-1.241901,"twenty":-36.397248,"median":-12.48183,"eighty":-1.877068,"marketCap":15215141},{"date":"2023-07-14","current":-1.204949,"twenty":-33.757987,"median":-12.48183,"eighty":-1.845821,"marketCap":14762426},{"date":"2023-07-21","current":-1.017513,"twenty":-33.635231,"median":-12.357585,"eighty":-1.824236,"marketCap":12466049},{"date":"2023-07-28","current":-0.905985,"twenty":-32.837315,"median":-12.357012,"eighty":-1.794379,"marketCap":11099674},{"date":"2023-08-04","current":-0.900255,"twenty":-31.425617,"median":-11.857738,"eighty":-1.773608,"marketCap":11029470},{"date":"2023-08-11","current":-0.63419,"twenty":-30.638859,"median":-11.386083,"eighty":-1.73785,"marketCap":7769771},{"date":"2023-08-18","current":-0.55807,"twenty":-30.103498,"median":-11.220378,"eighty":-1.68709,"marketCap":7062935},{"date":"2023-08-25","current":-0.523965,"twenty":-29.033151,"median":-11.097077,"eighty":-1.675707,"marketCap":6631311},{"date":"2023-09-01","current":-0.420938,"twenty":-28.224507,"median":-11.097077,"eighty":-1.659207,"marketCap":5327390},{"date":"2023-09-08","current":-0.350246,"twenty":-27.178685,"median":-11.097077,"eighty":-1.647519,"marketCap":4432713},{"date":"2023-09-15","current":-0.343819,"twenty":-25.922457,"median":-10.973777,"eighty":-1.629248,"marketCap":4351379},{"date":"2023-09-22","current":-0.313422,"twenty":-25.608909,"median":-10.850476,"eighty":-1.618329,"marketCap":3966668},{"date":"2023-09-29","current":-0.321326,"twenty":-23.64226,"median":-10.850476,"eighty":-1.601441,"marketCap":4066710},{"date":"2023-10-06","current":-0.289162,"twenty":-22.775869,"median":-10.688976,"eighty":-1.580196,"marketCap":3659632},{"date":"2023-10-13","current":-0.282767,"twenty":-22.573417,"median":-10.456607,"eighty":-1.555984,"marketCap":3578704},{"date":"2023-10-20","current":-0.29562,"twenty":-21.87715,"median":-10.357272,"eighty":-1.530122,"marketCap":3741373},{"date":"2023-10-27","current":-0.411298,"twenty":-20.708929,"median":-10.28233,"eighty":-1.525237,"marketCap":5205388},{"date":"2023-11-03","current":-0.385592,"twenty":-20.392025,"median":-10.008413,"eighty":-1.495062,"marketCap":4880052},{"date":"2023-11-10","current":-0.347032,"twenty":-20.25282,"median":-9.861161,"eighty":-1.453706,"marketCap":4392046},{"date":"2023-11-17","current":-0.527039,"twenty":-20.061981,"median":-9.742695,"eighty":-1.436505,"marketCap":6466068},{"date":"2023-11-24","current":-1.186185,"twenty":-20.052297,"median":-9.704796,"eighty":-1.418894,"marketCap":14552898},{"date":"2023-12-01","current":-0.739897,"twenty":-20.005723,"median":-9.704796,"eighty":-1.398059,"marketCap":9077550},{"date":"2023-12-08","current":-0.734025,"twenty":-19.855784,"median":-9.614269,"eighty":-1.379383,"marketCap":9005506},{"date":"2023-12-15","current":-0.757514,"twenty":-19.851774,"median":-9.529855,"eighty":-1.357844,"marketCap":9293682},{"date":"2023-12-22","current":-0.645942,"twenty":-19.450728,"median":-9.294762,"eighty":-1.3426,"marketCap":7924845},{"date":"2023-12-29","current":-0.734025,"twenty":-19.297293,"median":-9.178577,"eighty":-1.336307,"marketCap":9005506},{"date":"2024-01-05","current":-0.88681,"twenty":-18.799586,"median":-9.116636,"eighty":-1.327539,"marketCap":10879973},{"date":"2024-01-12","current":-0.924547,"twenty":-18.612428,"median":-9.098246,"eighty":-1.320866,"marketCap":11342950},{"date":"2024-01-19","current":-0.793298,"twenty":-18.4748,"median":-9.093511,"eighty":-1.311971,"marketCap":9732698},{"date":"2024-01-26","current":-0.812646,"twenty":-18.270731,"median":-8.999403,"eighty":-1.29484,"marketCap":9970081},{"date":"2024-02-02","current":-0.973886,"twenty":-18.114699,"median":-8.888116,"eighty":-1.287424,"marketCap":11948272},{"date":"2024-02-09","current":-0.838445,"twenty":-18.019487,"median":-8.794971,"eighty":-1.269673,"marketCap":10286591},{"date":"2024-02-16","current":-0.825545,"twenty":-17.817247,"median":-8.794971,"eighty":-1.256593,"marketCap":10128336},{"date":"2024-02-23","current":-0.780398,"twenty":-17.732346,"median":-8.790393,"eighty":-1.250053,"marketCap":9574443},{"date":"2024-03-01","current":-0.780398,"twenty":-17.646021,"median":-8.785645,"eighty":-1.245038,"marketCap":9574443},{"date":"2024-03-08","current":-0.806197,"twenty":-17.646021,"median":-8.666669,"eighty":-1.242787,"marketCap":9890953},{"date":"2024-03-15","current":-1.202078,"twenty":-17.560637,"median":-8.610667,"eighty":-1.232053,"marketCap":12640641},{"date":"2024-03-22","current":-1.061836,"twenty":-17.368294,"median":-8.491696,"eighty":-1.227587,"marketCap":11165900},{"date":"2024-03-28","current":-1.202078,"twenty":-17.227608,"median":-8.487276,"eighty":-1.21683,"marketCap":12640641},{"date":"2024-04-05","current":-1.282217,"twenty":-17.050112,"median":-8.393504,"eighty":-1.215841,"marketCap":13483351},{"date":"2024-04-12","current":-1.151992,"twenty":-16.459254,"median":-8.335718,"eighty":-1.212048,"marketCap":12113948},{"date":"2024-04-19","current":-1.051818,"twenty":-16.10474,"median":-8.21272,"eighty":-1.209834,"marketCap":11060561},{"date":"2024-04-26","current":-1.592754,"twenty":-15.910707,"median":-7.968666,"eighty":-1.204842,"marketCap":16748850},{"date":"2024-05-03","current":-1.151992,"twenty":-15.82702,"median":-7.731497,"eighty":-1.203538,"marketCap":12113948},{"date":"2024-05-10","current":-1.101905,"twenty":-15.82702,"median":-7.634408,"eighty":-1.200338,"marketCap":11587254},{"date":"2024-05-17","current":-1.061836,"twenty":-15.734838,"median":-7.48459,"eighty":-1.18456,"marketCap":11165900},{"date":"2024-05-24","current":-0.858149,"twenty":-15.582152,"median":-7.430234,"eighty":-1.178636,"marketCap":10834083},{"date":"2024-05-31","current":-0.715889,"twenty":-15.563236,"median":-7.382,"eighty":-1.173177,"marketCap":9038058},{"date":"2024-06-07","current":-0.658318,"twenty":-15.563236,"median":-7.319625,"eighty":-1.165754,"marketCap":8311221},{"date":"2024-06-14","current":-0.711685,"twenty":-15.563236,"median":-7.290579,"eighty":-1.161858,"marketCap":8984974},{"date":"2024-06-21","current":-0.630227,"twenty":-15.512687,"median":-7.276703,"eighty":-1.151992,"marketCap":7956573},{"date":"2024-06-28","current":-0.631856,"twenty":-15.351334,"median":-7.261532,"eighty":-1.146431,"marketCap":7977141},{"date":"2024-07-05","current":-0.62594,"twenty":-15.258759,"median":-7.232486,"eighty":-1.131572,"marketCap":7902447},{"date":"2024-07-12","current":-0.703024,"twenty":-15.199238,"median":-7.174394,"eighty":-1.12194,"marketCap":8875638},{"date":"2024-07-15","current":-0.678244,"twenty":-15.199238,"median":-7.116302,"eighty":-1.119798,"marketCap":8562788},{"date":"2024-08-02","current":-0.716281,"twenty":-14.887513,"median":-6.941989,"eighty":-1.109939,"marketCap":9043003},{"date":"2024-08-09","current":-0.651797,"twenty":-14.669052,"median":-6.792928,"eighty":-1.091888,"marketCap":8228892},{"date":"2024-08-16","current":-0.751707,"twenty":-14.498482,"median":-6.738702,"eighty":-1.08187,"marketCap":8549966},{"date":"2024-08-23","current":-0.748193,"twenty":-14.327911,"median":-6.622518,"eighty":-1.078179,"marketCap":8510005},{"date":"2024-08-30","current":-0.721532,"twenty":-14.296916,"median":-6.562136,"eighty":-1.072328,"marketCap":8206761},{"date":"2024-09-06","current":-0.68602,"twenty":-14.296916,"median":-6.469219,"eighty":-1.069821,"marketCap":7802835},{"date":"2024-09-13","current":-0.727328,"twenty":-14.296916,"median":-6.411345,"eighty":-1.061836,"marketCap":8272684},{"date":"2024-09-20","current":-0.696727,"twenty":-14.296916,"median":-6.353237,"eighty":-1.054133,"marketCap":7924624},{"date":"2024-09-27","current":-0.695504,"twenty":-14.296916,"median":-6.321565,"eighty":-1.044289,"marketCap":7910709},{"date":"2024-10-04","current":-0.671793,"twenty":-14.118204,"median":-6.222154,"eighty":-1.036389,"marketCap":7641025},{"date":"2024-10-11","current":-0.50013,"twenty":-14.066248,"median":-6.067323,"eighty":-1.01984,"marketCap":5688519},{"date":"2024-10-18","current":-0.576109,"twenty":-14.066248,"median":-5.964847,"eighty":-1.014835,"marketCap":6552704},{"date":"2024-10-25","current":-0.757678,"twenty":-13.83181,"median":-5.814279,"eighty":-0.991815,"marketCap":8617878},{"date":"2024-10-31","current":-0.758731,"twenty":-13.730013,"median":-5.719235,"eighty":-0.980335,"marketCap":8629864},{"date":"2024-11-08","current":-0.571578,"twenty":-13.730013,"median":-5.630104,"eighty":-0.95093,"marketCap":6501164},{"date":"2024-11-15","current":-0.58064,"twenty":-13.64563,"median":-5.578452,"eighty":-0.920835,"marketCap":6604243},{"date":"2024-11-22","current":-0.799583,"twenty":-13.418762,"median":-5.497016,"eighty":-0.900947,"marketCap":6591059},{"date":"2024-11-29","current":-0.787271,"twenty":-13.355558,"median":-5.239709,"eighty":-0.895748,"marketCap":6489564},{"date":"2024-12-06","current":-0.794995,"twenty":-13.233835,"median":-3.78108,"eighty":-0.88234,"marketCap":6553235},{"date":"2024-12-13","current":-0.764989,"twenty":-13.105921,"median":-3.672532,"eighty":-0.851444,"marketCap":6305897},{"date":"2024-12-20","current":-0.769,"twenty":-12.89,"median":-3.527801,"eighty":-0.838445,"marketCap":6338957},{"date":"2024-12-27","current":-0.830348,"twenty":-12.631501,"median":-3.093611,"eighty":-0.825442,"marketCap":6844653},{"date":"2025-01-03","current":-0.952598,"twenty":-12.48183,"median":-2.023095,"eighty":-0.825442,"marketCap":7852372},{"date":"2025-01-10","current":-0.793212,"twenty":-12.48183,"median":-1.965726,"eighty":-0.824584,"marketCap":6538542},{"date":"2025-01-17","current":-0.818613,"twenty":-12.48183,"median":-1.915211,"eighty":-0.816226,"marketCap":6747922},{"date":"2025-01-24","current":-0.79247,"twenty":-12.48183,"median":-1.86954,"eighty":-0.811335,"marketCap":6532419},{"date":"2025-01-31","current":-0.772417,"twenty":-12.48183,"median":-1.845312,"eighty":-0.806197,"marketCap":6367119},{"date":"2025-02-07","current":-0.680321,"twenty":-12.48183,"median":-1.822285,"eighty":-0.800781,"marketCap":5607963},{"date":"2025-02-14","current":-0.62239,"twenty":-12.48183,"median":-1.794164,"eighty":-0.798943,"marketCap":5130429},{"date":"2025-02-21","current":-0.868969,"twenty":-12.48183,"median":-1.774601,"eighty":-0.794876,"marketCap":7163009},{"date":"2025-02-28","current":-1.185362,"twenty":-12.48183,"median":-1.738663,"eighty":-0.794876,"marketCap":9771079},{"date":"2025-03-07","current":-0.94517,"twenty":-12.48183,"median":-1.686929,"eighty":-0.794817,"marketCap":7791150},{"date":"2025-03-14","current":-1.021967,"twenty":-12.48183,"median":-1.674611,"eighty":-0.794817,"marketCap":8424189},{"date":"2025-03-21","current":-0.987802,"twenty":-12.48183,"median":-1.658971,"eighty":-0.794817,"marketCap":8142566},{"date":"2025-03-28","current":-1.186848,"twenty":-12.48183,"median":-1.64007,"eighty":-0.794817,"marketCap":9783324},{"date":"2025-04-04","current":-1.358413,"twenty":-12.48183,"median":-1.633375,"eighty":-0.794817,"marketCap":11197559},{"date":"2025-04-11","current":-1.559687,"twenty":-12.48183,"median":-1.622615,"eighty":-0.794876,"marketCap":12856684},{"date":"2025-04-17","current":-2.422481,"twenty":-12.48183,"median":-1.616463,"eighty":-0.794876,"marketCap":11877127},{"date":"2025-04-25","current":-2.795995,"twenty":-12.48183,"median":-1.615552,"eighty":-0.794817,"marketCap":13708421},{"date":"2025-05-02","current":-5.324769,"twenty":-12.48183,"median":-1.615552,"eighty":-0.794817,"marketCap":15499093},{"date":"2025-05-09","current":-6.823976,"twenty":-12.48183,"median":-1.615552,"eighty":-0.794817,"marketCap":19862916},{"date":"2025-05-16","current":-6.668915,"twenty":-12.48183,"median":-1.615552,"eighty":-0.794817,"marketCap":19411570},{"date":"2025-05-23","current":-6.755518,"twenty":-12.48183,"median":-1.615552,"eighty":-0.794817,"marketCap":19663651},{"date":"2025-05-30","current":-7.816302,"twenty":-12.357356,"median":-1.615552,"eighty":-0.794817,"marketCap":22751332},{"date":"2025-06-06","current":-8.374609,"twenty":-12.307084,"median":-1.615552,"eighty":-0.794817,"marketCap":24376428},{"date":"2025-06-13","current":-10.328685,"twenty":-11.690443,"median":-1.615552,"eighty":-0.794817,"marketCap":30064261}],"updateTime":1750112493333}}}